T599-3717 Screening compound: 1-(5-cyclopropanecarbonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)-3-methoxypropan-1-one

T599-3717 Screening compound: 1-(5-cyclopropanecarbonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)-3-methoxypropan-1-one
T599-3717 Screening compound: 1-(5-cyclopropanecarbonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)-3-methoxypropan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T599-3717
1-(5-cyclopropanecarbonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)-3-methoxypropan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T599-3717

Molecular Formula

C17H22N2O3 (C17 H22 N2 O3)

Compound Name

1-(5-cyclopropanecarbonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)-3-methoxypropan-1-one

IUPAC name

1-(5-cyclopropanecarbonyl-2345-tetrahydro-1H-15-benzodiazepin-1-yl)-3-methoxypropan-1-one

SMILES

COCCC(N(CCC1)c(cccc2)c2N1C(C1CC1)=O)=O

InChI

InChI=1S/C17H22N2O3/c1-22-12-9-16(20)18-10-4-11-19(17(21)13-7-8-13)15-6-3-2-5-14(15)18/h2-3,5-6,13H,4,7-12H2,1H3

InChI Key

REYJSSOOLPZWRW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29009584

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

302.37

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.766

Distribution Coefficient, logD

1.766

Water Solubility, LogSw

-2.02

Polar Surface Area

39.884

Acid Dissociation Constant (pKa)

21.34

Base Dissociation Constant (pKb)

-0.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.90

T599-3717 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T599-3717 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T599-3717?
Check Price and Availability of T599-3717, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T599-3717 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T599-3717
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T599-3717
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T599-3717 available by request